UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                              WASHINGTON, DC 20549

                                    FORM 8-K

                             CURRENT REPORT PURSUANT
                          TO SECTION 13 OR 15(D) OF THE
                         SECURITIES EXCHANGE ACT OF 1934

         Date of report (Date of earliest event reported)     June 1, 2005
                                                         ----------------------

                           NEW YORK HEALTH CARE, INC.
--------------------------------------------------------------------------------
             (Exact Name of Registrant as Specified in Its Charter)

                                    New York
--------------------------------------------------------------------------------
                 (State or Other Jurisdiction of Incorporation)

               1-12451                                 11-2636089
--------------------------------------------------------------------------------
      (Commission File Number)              (IRS Employer Identification No.)

1850 McDonald Avenue, Brooklyn, New York                        11223
--------------------------------------------------------------------------------
(Address of Principal Executive Offices)                      (Zip Code)

                                 (212) 679-7778
--------------------------------------------------------------------------------
              (Registrant's Telephone Number, Including Area Code)

--------------------------------------------------------------------------------
          (Former Name or Former Address, if Changed Since Last Report)

      Check the  appropriate  box below if the Form 8-K  filing is  intended  to
simultaneously  satisfy the filing obligation of the registrant under any of the
following provisions (see General Instruction A.2. below):

      |_| Written  communications  pursuant to Rule 425 under the Securities Act
(17 CFR 230.425)

      |_| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17
CFR 240.14a-12)

      |_|  Pre-commencement  communications  pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b))

      |_|  Pre-commencement  communications  pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR 240.13e-4(c))

<PAGE>

Item 1.01 Entry into a material Definitive Agreement.

      In connection  with the June 1, 2005  appointment by New York Health Care,
Inc. (the "Company") of A. James Forbes, Jr. ("Forbes") as its Vice President of
Finance and Chief  Financial  Officer,  the Company  entered into an  employment
agreement with Mr. Forbes (the "Agreement").

      The  Agreement  provides  for  Forbes  to serve as the Vice  President  of
Finance and Chief Financial  Officer of the Company on an as needed basis not to
exceed  twenty (20) hours per week for a term  expiring on  December  31,  2005,
unless  terminated  earlier as  provided  for by the  Agreement.  The  Agreement
provides for Forbes to be compensated at the rate of $1,500 in U.S.  dollars per
full  business day or $200 per hour if less than a full day and to be reimbursed
for all  reasonable  and  necessary  business  and  travel  expenses  and  other
disbursements incurred by him on behalf of the Company in the performance of his
duties under the Agreement.  The Agreement  also requires  Forbes to comply with
certain  confidentiality and non-solicitation  provisions during the term of the
Agreement  and  for a  period  of  two  years  thereafter  with  respect  to the
confidentiality   provisions  and  one  year  thereafter  with  respect  to  the
non-solicitation provisions.

Item 3.02 Unregistered Sales of Equity Securities.

      On June 6, 2005 holders of an aggregate of 472,300 shares of the Company's
Series A  Convertible  Preferred  Stock,  who are all  former  directors  of the
Company,  converted their shares of preferred stock pursuant to the terms of the
preferred  stock into shares of the  Company's  common  stock.  An  aggregate of
314,865  shares of the  Company's  common stock will be issued to the holders of
the preferred stock as a result of the conversion. The issuance of the shares of
common stock is exempt from the  registration  requirement of the Securities Act
of 1933,  as amended  (the  "Act")  pursuant  to Section  3(a)(9) of the Act. No
commissions  or other  remuneration  was paid or given directly or indirectly in
connection with the conversions.

Item 5.02 Departure of Directors or Principal  Officers;  Election of Directors;
          Appointment of Principal Officers.

      On June 1, 2005, New York Health Care, Inc. (the  "Company")  appointed A.
James Forbes,  Jr. as Vice President of Finance and Chief  Financial  Officer of
the Company. A biography of Mr. Forbes follows:

      A. James Forbes,  age 61, joined the Company as Vice  President of Finance
and Chief Financial  Officer on June 1, 2005.  Since March 2001, he has been the
President of MedYield  LLC, a consulting  firm offering  strategic  planning and
financial services  solutions to pharmaceutical and medical products  companies.
From October 1995 to March 2001, he was Vice Chairman at AmeriCares, the world's
largest private international relief organization delivering  pharmaceuticals to
137 countries.  Mr. Forbes is a Certified Public Accountant and received his BBA
in Accounting  from Manhattan  College.  He is a past chairman of the Biomedical
Engineering  Alliance and Consortium  Foundation and co-founder of the Executive
Forum.

<PAGE>

Item 9.01 Financial Statements and Exhibits

(a)- (b) Not applicable.

(c)   Exhibits

      10.1  Employment Agreement between New York Health Care, Inc. and A. James
            Forbes, Jr. dated June 1, 2005.

                                   SIGNATURES

Pursuant  to the  requirements  of the  Securities  Exchange  Act of  1934,  the
Registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned thereunto duly authorized.

                                       NEW YORK HEALTH CARE, INC.
                                       (Registrant)

                                       By: /s/ Dennis M. O'Donnell
                                           -------------------------------------
                                           Dennis M. O'Donnell,
                                           Chief Executive Officer

Date: June 7, 2005
{"company-data": {"conformed-name": "NEW YORK HEALTH CARE INC", "cik": "0001018354", "assigned-sic": "8082", "irs-number": "112636089", "state-of-incorporation": "NY", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "001-12451", "film-number": "05882885"}, "business-address": {"street1": "1850 MCDONALD AVE", "city": "BROOKLYN", "state": "NY", "zip": "11223", "phone": "7184210500"}, "mail-address": {"street1": "1850 MCDONALD AVE", "city": "BROOKLYN", "state": "NY", "zip": "11223"}}
UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                              WASHINGTON, DC 20549

                                    FORM 8-K

                             CURRENT REPORT PURSUANT
                          TO SECTION 13 OR 15(D) OF THE
                         SECURITIES EXCHANGE ACT OF 1934

         Date of report (Date of earliest event reported)     June 1, 2005
                                                         ----------------------

                           NEW YORK HEALTH CARE, INC.
--------------------------------------------------------------------------------
             (Exact Name of Registrant as Specified in Its Charter)

                                    New York
--------------------------------------------------------------------------------
                 (State or Other Jurisdiction of Incorporation)

               1-12451                                 11-2636089
--------------------------------------------------------------------------------
      (Commission File Number)              (IRS Employer Identification No.)

1850 McDonald Avenue, Brooklyn, New York                        11223
--------------------------------------------------------------------------------
(Address of Principal Executive Offices)                      (Zip Code)

                                 (212) 679-7778
--------------------------------------------------------------------------------
              (Registrant's Telephone Number, Including Area Code)

--------------------------------------------------------------------------------
          (Former Name or Former Address, if Changed Since Last Report)

      Check the  appropriate  box below if the Form 8-K  filing is  intended  to
simultaneously  satisfy the filing obligation of the registrant under any of the
following provisions (see General Instruction A.2. below):

      |_| Written  communications  pursuant to Rule 425 under the Securities Act
(17 CFR 230.425)

      |_| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17
CFR 240.14a-12)

      |_|  Pre-commencement  communications  pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b))

      |_|  Pre-commencement  communications  pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR 240.13e-4(c))
Item 1.01 Entry into a material Definitive Agreement.

      In connection  with the June 1, 2005  appointment by New York Health Care,
Inc. (the "Company") of A. James Forbes, Jr. ("Forbes") as its Vice President of
Finance and Chief  Financial  Officer,  the Company  entered into an  employment
agreement with Mr. Forbes (the "Agreement").

      The  Agreement  provides  for  Forbes  to serve as the Vice  President  of
Finance and Chief Financial  Officer of the Company on an as needed basis not to
exceed  twenty (20) hours per week for a term  expiring on  December  31,  2005,
unless  terminated  earlier as  provided  for by the  Agreement.  The  Agreement
provides for Forbes to be compensated at the rate of $1,500 in U.S.  dollars per
full  business day or $200 per hour if less than a full day and to be reimbursed
for all  reasonable  and  necessary  business  and  travel  expenses  and  other
disbursements incurred by him on behalf of the Company in the performance of his
duties under the Agreement.  The Agreement  also requires  Forbes to comply with
certain  confidentiality and non-solicitation  provisions during the term of the
Agreement  and  for a  period  of  two  years  thereafter  with  respect  to the
confidentiality   provisions  and  one  year  thereafter  with  respect  to  the
non-solicitation provisions.

Item 3.02 Unregistered Sales of Equity Securities.

      On June 6, 2005 holders of an aggregate of 472,300 shares of the Company's
Series A  Convertible  Preferred  Stock,  who are all  former  directors  of the
Company,  converted their shares of preferred stock pursuant to the terms of the
preferred  stock into shares of the  Company's  common  stock.  An  aggregate of
314,865  shares of the  Company's  common stock will be issued to the holders of
the preferred stock as a result of the conversion. The issuance of the shares of
common stock is exempt from the  registration  requirement of the Securities Act
of 1933,  as amended  (the  "Act")  pursuant  to Section  3(a)(9) of the Act. No
commissions  or other  remuneration  was paid or given directly or indirectly in
connection with the conversions.

Item 5.02 Departure of Directors or Principal  Officers;  Election of Directors;
          Appointment of Principal Officers.

      On June 1, 2005, New York Health Care, Inc. (the  "Company")  appointed A.
James Forbes,  Jr. as Vice President of Finance and Chief  Financial  Officer of
the Company. A biography of Mr. Forbes follows:

      A. James Forbes,  age 61, joined the Company as Vice  President of Finance
and Chief Financial  Officer on June 1, 2005.  Since March 2001, he has been the
President of MedYield  LLC, a consulting  firm offering  strategic  planning and
financial services  solutions to pharmaceutical and medical products  companies.
From October 1995 to March 2001, he was Vice Chairman at AmeriCares, the world's
largest private international relief organization delivering  pharmaceuticals to
137 countries.  Mr. Forbes is a Certified Public Accountant and received his BBA
in Accounting  from Manhattan  College.  He is a past chairman of the Biomedical
Engineering  Alliance and Consortium  Foundation and co-founder of the Executive
Forum.
Item 9.01 Financial Statements and Exhibits

(a)- (b) Not applicable.

(c)   Exhibits

      10.1  Employment Agreement between New York Health Care, Inc. and A. James
            Forbes, Jr. dated June 1, 2005.

                                   SIGNATURES

Pursuant  to the  requirements  of the  Securities  Exchange  Act of  1934,  the
Registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned thereunto duly authorized.

                                       NEW YORK HEALTH CARE, INC.
                                       (Registrant)

                                       By: /s/ Dennis M. O'Donnell
                                           -------------------------------------
                                           Dennis M. O'Donnell,
                                           Chief Executive Officer

Date: June 7, 2005